Udenafil as a Therapeutic Option for Pulmonary Arterial Hypertension.
作者信息
Kim Hyung Yoon, Kim Kye Hun
机构信息
Department of Cardiovascular Medicine, Chonnam National University Hospital, Gwangju, Korea.
出版信息
Korean Circ J. 2019 Apr;49(4):361-362. doi: 10.4070/kcj.2019.0023. Epub 2019 Feb 14.
Abstract
摘要
相似文献
1
Udenafil as a Therapeutic Option for Pulmonary Arterial Hypertension.乌地那非作为肺动脉高压的一种治疗选择。
Korean Circ J. 2019 Apr;49(4):361-362. doi: 10.4070/kcj.2019.0023. Epub 2019 Feb 14.
2
Efficacy and Safety of Udenafil for the Treatment of Pulmonary Arterial Hypertension: a Placebo-controlled, Double-blind, Phase IIb Clinical Trial.乌地那非治疗肺动脉高压的疗效和安全性：一项安慰剂对照、双盲、IIb 期临床试验。
Clin Ther. 2019 Aug;41(8):1499-1507. doi: 10.1016/j.clinthera.2019.05.006. Epub 2019 Jun 13.
3
Acute Hemodynamic Changes after Single Administration of Udenafil in Pulmonary Arterial Hypertension: a Phase IIa Study.乌地那非单次给药后肺动脉高压患者的急性血流动力学变化：一项IIa期研究。
Korean Circ J. 2019 Apr;49(4):353-360. doi: 10.4070/kcj.2018.0281. Epub 2018 Dec 10.
4
Effect of udenafil on portal venous pressure and hepatic fibrosis in rats. A novel therapeutic option for portal hypertension.乌地那非对大鼠门静脉压力和肝纤维化的影响。门静脉高压症的一种新治疗选择。
Arzneimittelforschung. 2009;59(12):641-6. doi: 10.1055/s-0031-1296453.
5
Udenafil improves exercise capacity in patients with chronic obstructive pulmonary disease: a prospective study.乌地那非可改善慢性阻塞性肺疾病患者的运动能力：一项前瞻性研究。
COPD. 2012 Aug;9(5):499-504. doi: 10.3109/15412555.2012.694922. Epub 2012 Sep 4.
6
Therapeutic effects of udenafil on pressure-overload cardiac hypertrophy.乌地那非对压力超负荷性心肌肥大的治疗作用。
Hypertens Res. 2015 Sep;38(9):597-604. doi: 10.1038/hr.2015.46. Epub 2015 Apr 2.
7
Efficacy and safety of once-daily dosing of udenafil in the treatment of erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled trial.乌地那非每日 1 次治疗勃起功能障碍的疗效和安全性：多中心、随机、双盲、安慰剂对照试验的结果。
Eur Urol. 2011 Aug;60(2):380-7. doi: 10.1016/j.eururo.2011.03.025. Epub 2011 Apr 1.
8
The phosphodiesterase-5-inhibitor udenafil lowers portal pressure in compensated preascitic liver cirrhosis. A dose-finding phase-II-study.磷酸二酯酶-5抑制剂乌地那非可降低代偿期腹水前期肝硬化患者的门静脉压力。一项剂量探索性II期研究。
Dig Liver Dis. 2015 Feb;47(2):144-50. doi: 10.1016/j.dld.2014.10.018. Epub 2014 Nov 15.
9
PDE 5 inhibition with udenafil improves left ventricular systolic/diastolic functions and exercise capacity in patients with chronic heart failure with reduced ejection fraction; A 12-week, randomized, double-blind, placebo-controlled trial.使用乌地那非抑制磷酸二酯酶5可改善射血分数降低的慢性心力衰竭患者的左心室收缩/舒张功能及运动能力；一项为期12周的随机、双盲、安慰剂对照试验。
Am Heart J. 2015 Jun;169(6):813-822.e3. doi: 10.1016/j.ahj.2015.03.018. Epub 2015 Apr 1.
10
A therapeutic confirmatory study to assess the safety and efficacy of Zydena (udenafil) for the treatment of erectile dysfunction in male patients with diabetes mellitus.一项评估 Zydena（乌地那非）治疗糖尿病男性勃起功能障碍安全性和有效性的治疗确证研究。
J Sex Med. 2011 Jul;8(7):2048-61. doi: 10.1111/j.1743-6109.2011.02268.x. Epub 2011 May 6.
引用本文的文献
1
Repurposing of medications for pulmonary arterial hypertension.肺动脉高压药物的重新利用。
Pulm Circ. 2020 Nov 18;10(4):2045894020941494. doi: 10.1177/2045894020941494. eCollection 2020 Oct-Dec.
本文引用的文献
1
Acute Hemodynamic Changes after Single Administration of Udenafil in Pulmonary Arterial Hypertension: a Phase IIa Study.乌地那非单次给药后肺动脉高压患者的急性血流动力学变化：一项IIa期研究。
Korean Circ J. 2019 Apr;49(4):353-360. doi: 10.4070/kcj.2018.0281. Epub 2018 Dec 10.
2
New Therapeutic Target for Pulmonary Arterial Hypertension.肺动脉高压的新治疗靶点
Korean Circ J. 2018 Dec;48(12):1145-1147. doi: 10.4070/kcj.2018.0250.
3
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).2015年欧洲心脏病学会（ESC）/欧洲呼吸学会（ERS）肺动脉高压诊断和治疗指南：欧洲心脏病学会（ESC）和欧洲呼吸学会（ERS）肺动脉高压诊断和治疗联合工作组：得到以下组织认可：欧洲儿科和先天性心脏病协会（AEPC）、国际心肺移植学会（ISHLT）。
Eur Heart J. 2016 Jan 1;37(1):67-119. doi: 10.1093/eurheartj/ehv317. Epub 2015 Aug 29.
4
Therapeutic effects of udenafil on pressure-overload cardiac hypertrophy.乌地那非对压力超负荷性心肌肥大的治疗作用。
Hypertens Res. 2015 Sep;38(9):597-604. doi: 10.1038/hr.2015.46. Epub 2015 Apr 2.
5
The phosphodiesterase-5-inhibitor udenafil lowers portal pressure in compensated preascitic liver cirrhosis. A dose-finding phase-II-study.磷酸二酯酶-5抑制剂乌地那非可降低代偿期腹水前期肝硬化患者的门静脉压力。一项剂量探索性II期研究。
Dig Liver Dis. 2015 Feb;47(2):144-50. doi: 10.1016/j.dld.2014.10.018. Epub 2014 Nov 15.
6
ULTIMATE-SHF trial (UdenafiL Therapy to Improve symptoMAtology, exercise Tolerance and hEmodynamics in patients with chronic systolic heart failure): study protocol for a randomized, placebo-controlled, double-blind trial.ULTIMATE-SHF 试验（乌地那非治疗改善慢性收缩性心力衰竭患者的症状、运动耐量和血液动力学：一项随机、安慰剂对照、双盲试验的研究方案）
Trials. 2013 Jun 22;14:188. doi: 10.1186/1745-6215-14-188.
7
Udenafil: efficacy and tolerability in the management of erectile dysfunction.乌地那非：治疗勃起功能障碍的疗效和耐受性。
Ther Adv Urol. 2013 Apr;5(2):101-10. doi: 10.1177/1756287212470019.
8
An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry.从 REVEAL 注册研究评估肺动脉高压诊断后患者的长期生存。
Chest. 2012 Aug;142(2):448-456. doi: 10.1378/chest.11-1460.
9
Tadalafil therapy for pulmonary arterial hypertension.他达拉非治疗肺动脉高压。
Circulation. 2009 Jun 9;119(22):2894-903. doi: 10.1161/CIRCULATIONAHA.108.839274. Epub 2009 May 26.
10
Sildenafil citrate therapy for pulmonary arterial hypertension.枸橼酸西地那非治疗肺动脉高压
N Engl J Med. 2005 Nov 17;353(20):2148-57. doi: 10.1056/NEJMoa050010.
Zotero 插件